Tempus Wealth Planning LLC Raises Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Tempus Wealth Planning LLC increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 8.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,080 shares of the exchange traded fund’s stock after purchasing an additional 236 shares during the period. Tempus Wealth Planning LLC’s holdings in SPDR S&P Biotech ETF were worth $277,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Avior Wealth Management LLC increased its holdings in shares of SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after purchasing an additional 307 shares in the last quarter. Tidemark LLC grew its position in SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after buying an additional 199 shares during the period. Quintet Private Bank Europe S.A. purchased a new position in SPDR S&P Biotech ETF in the third quarter valued at about $40,000. ORG Wealth Partners LLC purchased a new position in SPDR S&P Biotech ETF in the third quarter valued at about $44,000. Finally, Howe & Rusling Inc. acquired a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at approximately $49,000.

SPDR S&P Biotech ETF Price Performance

XBI opened at $92.57 on Wednesday. The stock’s 50 day simple moving average is $92.99 and its 200 day simple moving average is $96.59. The stock has a market cap of $7.06 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.